Spots Global Cancer Trial Database for carcinoid tumor

Every month we try and update this database with for carcinoid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.	NCT01398306	Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle...	Blood sampling ...	18 Years -	University Medical Center Groningen
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor	NCT01175096	Neuroendocrine ... Carcinoid Tumor	RAD001 (everoli...	18 Years -	Guangdong Provincial People's Hospital
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors	NCT02038738	Neuroendocrine Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Carcinoid Tumor Islet Cell Tumo... Apudoma	68Ga-DOTATATE w...	18 Years -	Ochsner Health System
Natural History of Familial Carcinoid Tumor	NCT00646022	Carcinoid	[18F]-DOPA	18 Years -	National Institutes of Health Clinical Center (CC)
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors	NCT05636618	Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Tumor... Carcinoid Tumor Paraganglioma Pheochromocytom...	[212Pb]VMT-α-NE... [212Pb]VMT-α-NE...	18 Years - 90 Years	Perspective Therapeutics
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs	NCT04915144	Neuroendocrine ... Carcinoid Tumor Pulmonary Carci... Gastroenteropan... Vipoma Insulinoma Gastrinoma	177Lu-DOTATOC	19 Years -	British Columbia Cancer Agency
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors	NCT02038738	Neuroendocrine Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Carcinoid Tumor Islet Cell Tumo... Apudoma	68Ga-DOTATATE w...	18 Years -	Ochsner Health System
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma	NCT00780663	Neuroendocrine ... Carcinoid Tumor	Quarfloxin	18 Years -	Cylene Pharmaceuticals
Endoscopic Treatment of Bronchial Carcinoid Tumors	NCT03723499	Carcinoid Tumor	Medical data co...	18 Years -	Centre Hospitalier Universitaire de Saint Etienne
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors	NCT02399215	Carcinoid Tumor Metastatic Carc... Neuroendocrine ...	Laboratory Biom... Nintedanib Pharmacological... Quality-of-Life...	18 Years -	Roswell Park Cancer Institute
Personalized PRRT of Neuroendocrine Tumors	NCT02754297	Neuroendocrine ... Carcinoid Tumor Carcinoma, Neur...	177Lu-Octreotat...	18 Years -	CHU de Quebec-Universite Laval
Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors	NCT03420521	Neuroendocrine ... Carcinoid Tumor	Nivolumab Ipilimumab	18 Years - 100 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Study of Axitinib in Advanced Carcinoid Tumors	NCT01435122	Carcinoid Tumor	Axitinib	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
A Study of Axitinib in Advanced Carcinoid Tumors	NCT01435122	Carcinoid Tumor	Axitinib	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors	NCT00804336	Neuroendocrine ... Carcinoid Tumor Pancreatic Neur...	SOM230 RAD001	18 Years -	Dana-Farber Cancer Institute
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma	NCT00780663	Neuroendocrine ... Carcinoid Tumor	Quarfloxin	18 Years -	Cylene Pharmaceuticals
SwissNET - a Registry for Neuroendocrine Tumours in Switzerland	NCT01039922	Neuroendocrine ... Carcinoid Tumor		-	Insel Gruppe AG, University Hospital Bern
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors	NCT01024387	Neuroendocrine ... Carcinoid Tumor Pancreatic Neur...	AMG 479	18 Years -	Dana-Farber Cancer Institute
SwissNET - a Registry for Neuroendocrine Tumours in Switzerland	NCT01039922	Neuroendocrine ... Carcinoid Tumor		-	Insel Gruppe AG, University Hospital Bern
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors	NCT04993261	Carcinoid Syndr... Carcinoid Tumor Digestive Syste... Metastatic Carc...	Dual-Energy Com...	18 Years -	M.D. Anderson Cancer Center
Cabozantinib and Nivolumab for Carcinoid Tumors	NCT04197310	Carcinoid Tumor Carcinoid Tumor... Neuroendocrine ...	Nivolumab Cabozantinib	18 Years -	Dana-Farber Cancer Institute
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.	NCT01398306	Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle...	Blood sampling ...	18 Years -	University Medical Center Groningen
Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	NCT01466036	Carcinoid Tumor Pancreatic Neur...	Cabozantinib	18 Years -	Dana-Farber Cancer Institute
Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors	NCT03420521	Neuroendocrine ... Carcinoid Tumor	Nivolumab Ipilimumab	18 Years - 100 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Natural History of Familial Carcinoid Tumor	NCT00646022	Carcinoid	[18F]-DOPA	18 Years -	National Institutes of Health Clinical Center (CC)
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome	NCT00774930	Carcinoid Syndr...	Lanreotide Placebo	18 Years -	Ipsen
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy	NCT05477576	GEP-NET Gastroenteropan... Gastroenteropan... Neuroendocrine ... Carcinoid Carcinoid Tumor Pancreatic NET	RYZ101 Everolimus 10 m... Sunitinib 37.5 ... Octreotide LAR ... Lanreotide 120M...	18 Years -	RayzeBio, Inc.
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor	NCT00412061	Carcinoid Tumor Malignant Carci...	Octreotide Placebo Everolimus	18 Years -	Novartis
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	NCT04907643	Cancer Pain Visceral Pain Gastrointestina... Cancer of Gastr... Small Intestine... Pancreas Cancer Liver Cancer Colon Cancer Biliary Tract C... Stomach Cancer Rectum Cancer Peritoneal Canc... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Small Intestine... Small Intestine... Small Intestine... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Liver Cancer St... Liver Cancer St... Liver Cancer St... Liver Cancer St... Colon Cancer St... Colon Cancer St... Stomach Cancer ... Stomach Cancer ... Stomach Cancer ... Rectum Cancer, ... Gastrointestina... Anal Cancer Anal Cancer Sta... Anal Cancer Sta... Anal Cancer Rec... Anal Cancer Met... Anal Cancer, St... Anal Cancer, St... Appendix Cancer Ampullary Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Carcinoid Tumor Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Large Intestine... Esophagus Cance... Esophagus Cance... Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Gallbladder Can... Gastric (Stomac... Neuroendocrine ... Peritoneum Canc... Rectal Cancer Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Bile Duct Cance... Bile Duct Cance...	PICO G2 4k	18 Years - 99 Years	Cedars-Sinai Medical Center
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor	NCT01175096	Neuroendocrine ... Carcinoid Tumor	RAD001 (everoli...	18 Years -	Guangdong Provincial People's Hospital
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
68Ga-DOTATATE PET Scan in Neuroendocrine Cancer	NCT01396382	Neuroendocrine ...	68Ga-DOTATATE P...	18 Years -	Vanderbilt-Ingram Cancer Center
Natural History of Familial Carcinoid Tumor	NCT00646022	Carcinoid	[18F]-DOPA	18 Years -	National Institutes of Health Clinical Center (CC)
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	NCT01466036	Carcinoid Tumor Pancreatic Neur...	Cabozantinib	18 Years -	Dana-Farber Cancer Institute
18F-FDOPA PET in Neuroendocrine Tumours	NCT02431715	Thyroid Cancer,... Carcinoid Tumor Pheochromocytom... Paraganglioma Insulinoma Neuroblastoma	[18 F]-6-L-fluo...	1 Month -	British Columbia Cancer Agency
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors	NCT00804336	Neuroendocrine ... Carcinoid Tumor Pancreatic Neur...	SOM230 RAD001	18 Years -	Dana-Farber Cancer Institute
A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors	NCT00328497	Carcinoid Tumor	Panzem (2-metho...	18 Years -	CASI Pharmaceuticals, Inc.
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	NCT03375320	Carcinoid Tumor Functioning Pan... Intermediate Gr... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Low Grade Lung ... Lung Neuroendoc... Lung Neuroendoc... Metastatic Dige... Metastatic Dige... Metastatic Lung... Metastatic Lung... Metastatic Panc... Metastatic Panc... Metastatic Thym... Neuroendocrine ... Neuroendocrine ... Non-Functioning... Pancreatic Sero... Thymic Neuroend... Unresectable Di... Unresectable Di... Unresectable Lu... Unresectable Pa... Unresectable Th...	Cabozantinib S-... Computed Tomogr... Magnetic Resona... Placebo Adminis... Quality-of-Life... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	NCT04907643	Cancer Pain Visceral Pain Gastrointestina... Cancer of Gastr... Small Intestine... Pancreas Cancer Liver Cancer Colon Cancer Biliary Tract C... Stomach Cancer Rectum Cancer Peritoneal Canc... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Small Intestine... Small Intestine... Small Intestine... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Liver Cancer St... Liver Cancer St... Liver Cancer St... Liver Cancer St... Colon Cancer St... Colon Cancer St... Stomach Cancer ... Stomach Cancer ... Stomach Cancer ... Rectum Cancer, ... Gastrointestina... Anal Cancer Anal Cancer Sta... Anal Cancer Sta... Anal Cancer Rec... Anal Cancer Met... Anal Cancer, St... Anal Cancer, St... Appendix Cancer Ampullary Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Carcinoid Tumor Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Large Intestine... Esophagus Cance... Esophagus Cance... Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Gallbladder Can... Gastric (Stomac... Neuroendocrine ... Peritoneum Canc... Rectal Cancer Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Bile Duct Cance... Bile Duct Cance...	PICO G2 4k	18 Years - 99 Years	Cedars-Sinai Medical Center
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs	NCT04915144	Neuroendocrine ... Carcinoid Tumor Pulmonary Carci... Gastroenteropan... Vipoma Insulinoma Gastrinoma	177Lu-DOTATOC	19 Years -	British Columbia Cancer Agency
Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy	NCT04039516	Carcinoid Heart... Carcinoid Syndr... Carcinoid Tumor	Lutathera	18 Years -	King's College Hospital NHS Trust
Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors	NCT00942682	Neuroendocrine ... Carcinoid Tumor Pancreatic Neur...	Sorafenib RAD001	18 Years -	Dana-Farber Cancer Institute
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)	NCT02628067	Advanced Cancer Anal Carcinoma Anal Cancer Biliary Cancer Cholangiocarcin... Bile Duct Cance... Neuroendocrine ... Carcinoid Tumor Endometrial Car... Endometrial Can... Cervical Carcin... Cervical Cancer Vulvar Carcinom... Vulvar Cancer Small Cell Lung... Small Cell Lung... Mesothelioma Thyroid Carcino... Thyroid Cancer Salivary Gland ... Salivary Gland ... Salivary Cancer Parotid Gland C... Advanced Solid ... Colorectal Carc...	pembrolizumab pembrolizumab	18 Years -	Merck Sharp & Dohme LLC
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor	NCT00412061	Carcinoid Tumor Malignant Carci...	Octreotide Placebo Everolimus	18 Years -	Novartis
Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy	NCT04039516	Carcinoid Heart... Carcinoid Syndr... Carcinoid Tumor	Lutathera	18 Years -	King's College Hospital NHS Trust
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors	NCT04993261	Carcinoid Syndr... Carcinoid Tumor Digestive Syste... Metastatic Carc...	Dual-Energy Com...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: